Managing a modern pharmaceutical supply chain is like building a house during a storm; it is no longer enough to ensure the ...

Frits Stulp, Implement Consulting, says AI and global collaboration are key to addressing patent cliffs and accelerating ...

André Cerbe, CEO of Schlafender Hase, spoke with Pharmaceutical Technology® about the disruptions the pharma industry faced ...

The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...

Ultimately, these advancements suggest a more integrated ecosystem. Trusted regulatory spaces function like a communal ...

AI-driven decision engines and intelligent orchestration layers are crucial for navigating geopolitical risks and ...

The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...

From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...

On Dec. 19, 2025, Emer Cooke, executive director of the European Medicines Agency (EMA), published highlights of the agency’s accomplishments in 2025, which marked three decades since its inception.

Britton Jimenez, SVP of Sales and Marketing at Codexis, explains how the ECO Synthesis® Manufacturing Platform overcomes the ...

Mandy Vink, VP of Business Development at Codexis, explains how the company leverages over 20 years of expertise in small-molecule APIs to advance biocatalysis across pharma.

Now, with the European Union Health Technology Assessment (HTA) regulation coming into force as part of the required Joint Clinical Assessment (JCA) for oncology and advanced therapy medicinal ...